RecallRadar

FDA Drug recall D-0365-2022

Carbamazepine Tablets, USP 200 mg 100 Tablets Rx only NDC 13668-268-01 Manufactured by: Torrent Pharmaceuticals Ltd

On 2022-01-19 the FDA classified a Class II recall of Carbamazepine Tablets, USP 200 mg 100 Tablets Rx only NDC 13668-268-01 Manufactured by: Torrent Pharmaceuticals Ltd by Torrent Pharma, citing failed Dissolution Specifications.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0365-2022
ClassificationClass II
Statusterminated
Initiated2021-12-02
Published2022-01-19
Last updated2026-09-13 11:52 UTC
CompanyTorrent Pharma
DistributionUS

Product

Carbamazepine Tablets, USP 200 mg 100 Tablets Rx only NDC 13668-268-01 Manufactured by: Torrent Pharmaceuticals Ltd. Bharuch-392130, India Manufactured for: Torrent Pharma Inc., Basking Ridge, NJ 07920.

Reason

Failed Dissolution Specifications

Identifiers

ndc13668-268-30
ndc13668-268-01
ndc13668-268-10
ndc13668-268-31
ndc13668-268-05
ndc13668-271-01
ndc13668-271-10
ndc13668-271-49
ndc13668-271-05
code_infoBatch: 4J11G002 Exp. 08/2024

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0365-2022%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.